Cargando…

Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study

Drug-resistant tuberculosis (DR-TB) management is often linked with a higher rate of adverse drug reactions (ADRs) needing effective and timely management of these ADRs, which, if left untreated, may result in a higher rate of loss to follow-up of drug-resistant patients. Study objective: The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Massud, Asif, Syed Sulaiman, Syed Azhar, Ahmad, Nafees, Shafqat, Muhammad, Chiau Ming, Long, Khan, Amer Hayat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211428/
https://www.ncbi.nlm.nih.gov/pubmed/35747749
http://dx.doi.org/10.3389/fphar.2022.883483
_version_ 1784730358839771136
author Massud, Asif
Syed Sulaiman, Syed Azhar
Ahmad, Nafees
Shafqat, Muhammad
Chiau Ming, Long
Khan, Amer Hayat
author_facet Massud, Asif
Syed Sulaiman, Syed Azhar
Ahmad, Nafees
Shafqat, Muhammad
Chiau Ming, Long
Khan, Amer Hayat
author_sort Massud, Asif
collection PubMed
description Drug-resistant tuberculosis (DR-TB) management is often linked with a higher rate of adverse drug reactions (ADRs) needing effective and timely management of these ADRs, which, if left untreated, may result in a higher rate of loss to follow-up of drug-resistant patients. Study objective: The study was aimed at prospectively identifying the nature, frequency, suspected drugs, and management approaches for ADRs along with risk factors of ADRs occurrence among DR-TB patients at Nishtar Medical University, Hospital, Multan, Pakistan. Materials and Methods: The prospective study included all the DR-TB patients enrolled for treatment from January 2016 to May 2017 at the study site. Patients were evaluated for the treatment-induced ADRs as per standard criteria of the National Tuberculosis Program, Pakistan. Multivariate logistic regression was used to assess the independent variables associated with the occurrence of ADRs. Results: Out of 271 DR-TB patients included in the final analysis, it was observed that 55 patients (20.3%) experienced at least three ADRs. A total of 50 (18.5%) patients experienced zero adverse effects, while 15 (5.5%), 33 (12.2%), and 53 (19.6%) patients experienced one, two, and four ADRs, respectively. Gastrointestinal disturbances (66.7%), nervous system disorders (59.4%), and electrolyte disturbances (55.7%) remained the highest reported ADRs during therapy, followed by arthralgia (49.1%), ototoxicity (24%), pruritic reactions/rash (12.9%), dyspnoea (12.5%), and tinnitus (8.8%). Pulmonary cavitation at the baseline visit (p-value 0.001, OR 3.419; 95% CI (1.694–6.902) was significantly associated with the occurrence of ADRs among DR-TB patients. Conclusion: The frequency of ADRs was high among the study cohort; however, these were managed effectively. Patients with recognized risk factors for ADRs occurrence need continuous clinical management efforts.
format Online
Article
Text
id pubmed-9211428
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92114282022-06-22 Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study Massud, Asif Syed Sulaiman, Syed Azhar Ahmad, Nafees Shafqat, Muhammad Chiau Ming, Long Khan, Amer Hayat Front Pharmacol Pharmacology Drug-resistant tuberculosis (DR-TB) management is often linked with a higher rate of adverse drug reactions (ADRs) needing effective and timely management of these ADRs, which, if left untreated, may result in a higher rate of loss to follow-up of drug-resistant patients. Study objective: The study was aimed at prospectively identifying the nature, frequency, suspected drugs, and management approaches for ADRs along with risk factors of ADRs occurrence among DR-TB patients at Nishtar Medical University, Hospital, Multan, Pakistan. Materials and Methods: The prospective study included all the DR-TB patients enrolled for treatment from January 2016 to May 2017 at the study site. Patients were evaluated for the treatment-induced ADRs as per standard criteria of the National Tuberculosis Program, Pakistan. Multivariate logistic regression was used to assess the independent variables associated with the occurrence of ADRs. Results: Out of 271 DR-TB patients included in the final analysis, it was observed that 55 patients (20.3%) experienced at least three ADRs. A total of 50 (18.5%) patients experienced zero adverse effects, while 15 (5.5%), 33 (12.2%), and 53 (19.6%) patients experienced one, two, and four ADRs, respectively. Gastrointestinal disturbances (66.7%), nervous system disorders (59.4%), and electrolyte disturbances (55.7%) remained the highest reported ADRs during therapy, followed by arthralgia (49.1%), ototoxicity (24%), pruritic reactions/rash (12.9%), dyspnoea (12.5%), and tinnitus (8.8%). Pulmonary cavitation at the baseline visit (p-value 0.001, OR 3.419; 95% CI (1.694–6.902) was significantly associated with the occurrence of ADRs among DR-TB patients. Conclusion: The frequency of ADRs was high among the study cohort; however, these were managed effectively. Patients with recognized risk factors for ADRs occurrence need continuous clinical management efforts. Frontiers Media S.A. 2022-06-02 /pmc/articles/PMC9211428/ /pubmed/35747749 http://dx.doi.org/10.3389/fphar.2022.883483 Text en Copyright © 2022 Massud, Syed Sulaiman, Ahmad, Shafqat, Chiau Ming and Khan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Massud, Asif
Syed Sulaiman, Syed Azhar
Ahmad, Nafees
Shafqat, Muhammad
Chiau Ming, Long
Khan, Amer Hayat
Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
title Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
title_full Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
title_fullStr Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
title_full_unstemmed Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
title_short Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
title_sort frequency and management of adverse drug reactions among drug-resistant tuberculosis patients: analysis from a prospective study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211428/
https://www.ncbi.nlm.nih.gov/pubmed/35747749
http://dx.doi.org/10.3389/fphar.2022.883483
work_keys_str_mv AT massudasif frequencyandmanagementofadversedrugreactionsamongdrugresistanttuberculosispatientsanalysisfromaprospectivestudy
AT syedsulaimansyedazhar frequencyandmanagementofadversedrugreactionsamongdrugresistanttuberculosispatientsanalysisfromaprospectivestudy
AT ahmadnafees frequencyandmanagementofadversedrugreactionsamongdrugresistanttuberculosispatientsanalysisfromaprospectivestudy
AT shafqatmuhammad frequencyandmanagementofadversedrugreactionsamongdrugresistanttuberculosispatientsanalysisfromaprospectivestudy
AT chiauminglong frequencyandmanagementofadversedrugreactionsamongdrugresistanttuberculosispatientsanalysisfromaprospectivestudy
AT khanamerhayat frequencyandmanagementofadversedrugreactionsamongdrugresistanttuberculosispatientsanalysisfromaprospectivestudy